Skip to main content
. Author manuscript; available in PMC: 2021 May 11.
Published before final editing as: Am J Chin Med. 2018 Oct 4:1–15. doi: 10.1142/S0192415X18500829

Figure 4.

Figure 4.

Protein expression of NRF2 and its target enzymes in HT29 cells treated with QYJD, matrine and oxymatrine. (A) Representative images of Western blots from three independent experiments. Sulforaphane (SFN, 5 μM) was used as a positive control for activating NRF2. β-ACTIN served as a loading control. (B–D) Relative protein levels of Nrf2, HO-1 and NQO1 induced by QYJD, matrine and oxymatrine in HT29 cells. All experiments were performed three times. *P < 0:05, one-way ANOVA; compared to the vehicle-treated group.